论文信息 - EP02.04-005 Phase II NAUTIKA1 Study of Targeted Therapies in Stage II-III NSCLC: Preliminary Data of Neoadjuvant Alectinib for ALK+ NSCLC - 字舞流文

EP02.04-005 Phase II NAUTIKA1 Study of Targeted Therapies in Stage II-III NSCLC: Preliminary Data of Neoadjuvant Alectinib for ALK+ NSCLC

J. Chaft | B. Sepesi | E. Toloza | K. Schulze | J. Lee | H. Pass | J. Heymach | B. Johnson | J. Lin | I. Bara | J. Heymach | C. Ngiam | M. Johnson | Q. Zhu | E. Brandão | B. Ding | I. Bāra